Botanical species · safety record

Anemone pratensis

The EFSA Compendium of Botanicals holds 3 constituent measurements for Anemone pratensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anemone pratensis L.

3Constituent measurements

0Safety records

2Cited sources

0Licensed products (Canada)

Also recorded as

Pulsatilla pratensis (L.) Mill.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Furan derivatives	Leaves	—	—	—	Resolve DOI
Protoanemonin	Unspecified	Solvent extraction	≤ 0.548 Microgram/gram	HPLC with standard detection methods	Resolve DOI
Protoanemonin	Unspecified	Solvent extraction	≥ 0.134 Microgram/gram	HPLC with standard detection methods	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Schrenk, D., Merz, K. -H., Jochims, K. Feasibility study of nonclinical safety assessments on homeopathic preparations using the example of protoanemonin in Pulsatilla pratensis L. . Regulatory toxicology and pharmacology, 2013, vol. 66, no. 1, p. 104-108. DOI
JUNG, H D., SCHROEDER, H. Antimycotic efficacy of the plant extracts .. Archiv fur klinische und experimentelle dermatologie, 1954, vol. 197, no. 2, p. 130-44. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature